RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 56 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,412 | -85.4% | 3,160 | -74.4% | 0.00% | -50.0% |
| Q4 2021 | $119,635 | -47.8% | 12,359 | -3.7% | 0.00% | -33.3% |
| Q3 2021 | $229,365 | -26.8% | 12,828 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $313,131 | +15.8% | 12,828 | +25.7% | 0.00% | 0.0% |
| Q1 2021 | $270,512 | +273.4% | 10,208 | -15.7% | 0.00% | +300.0% |
| Q2 2020 | $72,442 | -28.4% | 12,114 | +13.7% | 0.00% | -50.0% |
| Q4 2019 | $101,204 | +8.6% | 10,653 | -10.2% | 0.00% | 0.0% |
| Q3 2019 | $93,156 | -50.1% | 11,867 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $186,668 | -13.1% | 11,867 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $214,793 | +85.8% | 11,867 | +65.0% | 0.00% | +100.0% |
| Q4 2018 | $115,631 | -38.3% | 7,191 | -7.9% | 0.00% | -33.3% |
| Q3 2018 | $187,416 | – | 7,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $11,652,000 | 19.67% |
| Flagship Pioneering Inc. | 38,296,526 | $170,419,000 | 7.99% |
| HARBOURVEST PARTNERS LLC | 986,878 | $4,392,000 | 2.12% |
| Abbot Financial Management, Inc. | 563,500 | $2,508,000 | 2.04% |
| Artal Group S.A. | 3,883,791 | $17,283,000 | 0.73% |
| ARK Investment Management | 318,121 | $1,416,000 | 0.04% |
| Walleye Capital LLC | 34,000 | $151,000 | 0.03% |
| Tekla Capital Management LLC | 155,982 | $694,000 | 0.03% |
| Baillie Gifford | 4,256,900 | $18,943,000 | 0.02% |
| FEDERATED HERMES, INC. | 600,000 | $2,670,000 | 0.01% |